| AMRX Stock | | | USD 8.32 0.09 1.07% |
Amneal Pharmaceuticals, financial indicator trend analysis is way more than just evaluating Amneal Pharmaceuticals, prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Amneal Pharmaceuticals, is a good investment. Please check the relationship between Amneal Pharmaceuticals, Accounts Payable and its Current Deferred Revenue accounts. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Amneal Pharmaceuticals, Class. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in metropolitan statistical area.
Accounts Payable vs Current Deferred Revenue
Accounts Payable vs Current Deferred Revenue Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Amneal Pharmaceuticals, Accounts Payable account and
Current Deferred Revenue. At this time, the significance of the direction appears to have almost no relationship.
The correlation between Amneal Pharmaceuticals,'s Accounts Payable and Current Deferred Revenue is 0.18. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Current Deferred Revenue in the same time period over historical financial statements of Amneal Pharmaceuticals, Class, assuming nothing else is changed. The correlation between historical values of Amneal Pharmaceuticals,'s Accounts Payable and Current Deferred Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Amneal Pharmaceuticals, Class are associated (or correlated) with its Current Deferred Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Current Deferred Revenue has no effect on the direction of Accounts Payable i.e., Amneal Pharmaceuticals,'s Accounts Payable and Current Deferred Revenue go up and down completely randomly.
Correlation Coefficient | 0.18 |
| Relationship Direction | Positive |
| Relationship Strength | Insignificant |
Accounts Payable
An accounting item on the balance sheet that represents Amneal Pharmaceuticals, obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Amneal Pharmaceuticals, are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Current Deferred Revenue
Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.
Most indicators from Amneal Pharmaceuticals,'s fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Amneal Pharmaceuticals, current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Amneal Pharmaceuticals, Class. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in metropolitan statistical area.
At this time, Amneal Pharmaceuticals,'s
Enterprise Value Over EBITDA is fairly stable compared to the past year.
Enterprise Value Multiple is likely to rise to 7.82 in 2024, whereas
Selling General Administrative is likely to drop slightly above 281.2
M in 2024.
Amneal Pharmaceuticals, fundamental ratios Correlations
Click cells to compare fundamentals
Amneal Pharmaceuticals, Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Amneal Pharmaceuticals, fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Amneal Stock Analysis
When running Amneal Pharmaceuticals,'s price analysis, check to
measure Amneal Pharmaceuticals,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amneal Pharmaceuticals, is operating at the current time. Most of Amneal Pharmaceuticals,'s value examination focuses on studying past and present price action to
predict the probability of Amneal Pharmaceuticals,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amneal Pharmaceuticals,'s price. Additionally, you may evaluate how the addition of Amneal Pharmaceuticals, to your portfolios can decrease your overall portfolio volatility.